New tuberculosis tests and drugs remain out of reach.

Makoni, Munyaradzi

Makoni, Munyaradzi.

Lancet Infect Dis ; 21(2): 174, 2021 02.

Article in English | MEDLINE | ID: covidwho-1052041

Subject(s)

Antitubercular Agents/therapeutic use; Tuberculosis, Multidrug-Resistant/diagnosis; Tuberculosis, Multidrug-Resistant/drug therapy; Antitubercular Agents/administration & dosage; Antitubercular Agents/economics; COVID-19; Drug Costs; HIV Infections/complications; Health Policy; Humans; Practice Guidelines as Topic; SARS-CoV-2; Tuberculosis, Multidrug-Resistant/complications; World Health Organization

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis, Multidrug-Resistant / Antitubercular Agents Type of study: Diagnostic study / Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: Lancet Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google